BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30868056)

  • 1. Histone deacetylase 2 is involved in DNA damage-mediated cell death of human osteosarcoma cells through stimulation of the ATM/p53 pathway.
    Sun D; Yu M; Li Y; Xing H; Gao Y; Huang Z; Hao W; Lu K; Kong C; Shimozato O; Ozaki T; Zhu Y
    FEBS Open Bio; 2019 Mar; 9(3):478-489. PubMed ID: 30868056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P65-mediated miR-590 inhibition modulates the chemoresistance of osteosarcoma to doxorubicin through targeting wild-type p53-induced phosphatase 1.
    Long X; Lin XJ
    J Cell Biochem; 2019 Apr; 120(4):5652-5665. PubMed ID: 30387173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Runt-related transcription factor 2 attenuates the transcriptional activity as well as DNA damage-mediated induction of pro-apoptotic TAp73 to regulate chemosensitivity.
    Ozaki T; Sugimoto H; Nakamura M; Hiraoka K; Yoda H; Sang M; Fujiwara K; Nagase H
    FEBS J; 2015 Jan; 282(1):114-28. PubMed ID: 25331851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of histone deacetylase 2 induces p53-dependent survivin downregulation through MDM2 proteasomal degradation.
    Seo SK; Hwang CS; Choe TB; Hong SI; Yi JY; Hwang SG; Lee HG; Oh ST; Lee YH; Park IC
    Oncotarget; 2015 Sep; 6(28):26528-40. PubMed ID: 25605253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage.
    Ozaki T; Wu D; Sugimoto H; Nagase H; Nakagawara A
    Cell Death Dis; 2013 Apr; 4(4):e610. PubMed ID: 23618908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase regulation of ATM-mediated DNA damage signaling.
    Thurn KT; Thomas S; Raha P; Qureshi I; Munster PN
    Mol Cancer Ther; 2013 Oct; 12(10):2078-87. PubMed ID: 23939379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of autophagy in chemoresistance: regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA-PKcs and PARP-1.
    Yoon JH; Ahn SG; Lee BH; Jung SH; Oh SH
    Biochem Pharmacol; 2012 Mar; 83(6):747-57. PubMed ID: 22226932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theabrownin triggers DNA damage to suppress human osteosarcoma U2OS cells by activating p53 signalling pathway.
    Jin W; Zhou L; Yan B; Yan L; Liu F; Tong P; Yu W; Dong X; Xie L; Zhang J; Xu Y; Li C; Yuan Q; Shan L; Efferth T
    J Cell Mol Med; 2018 Sep; 22(9):4423-4436. PubMed ID: 29993186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LRRK2 interacts with ATM and regulates Mdm2-p53 cell proliferation axis in response to genotoxic stress.
    Chen Z; Cao Z; Zhang W; Gu M; Zhou ZD; Li B; Li J; Tan EK; Zeng L
    Hum Mol Genet; 2017 Nov; 26(22):4494-4505. PubMed ID: 28973420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins.
    Jung KH; Noh JH; Kim JK; Eun JW; Bae HJ; Xie HJ; Chang YG; Kim MG; Park H; Lee JY; Nam SW
    J Cell Biochem; 2012 Jun; 113(6):2167-77. PubMed ID: 22492270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDAC1 and HDAC2 integrate checkpoint kinase phosphorylation and cell fate through the phosphatase-2A subunit PR130.
    Göder A; Emmerich C; Nikolova T; Kiweler N; Schreiber M; Kühl T; Imhof D; Christmann M; Heinzel T; Schneider G; Krämer OH
    Nat Commun; 2018 Feb; 9(1):764. PubMed ID: 29472538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamically regulated sumoylation of HDAC2 controls p53 deacetylation and restricts apoptosis following genotoxic stress.
    Brandl A; Wagner T; Uhlig KM; Knauer SK; Stauber RH; Melchior F; Schneider G; Heinzel T; Krämer OH
    J Mol Cell Biol; 2012 Oct; 4(5):284-93. PubMed ID: 22493095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-alpha enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin by p53-dependent apoptosis.
    Yuan XW; Zhu XF; Huang XF; Sheng PY; He AS; Yang ZB; Deng R; Feng GK; Liao WM
    Acta Pharmacol Sin; 2007 Nov; 28(11):1835-41. PubMed ID: 17959036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RUNX3 modulates DNA damage-mediated phosphorylation of tumor suppressor p53 at Ser-15 and acts as a co-activator for p53.
    Yamada C; Ozaki T; Ando K; Suenaga Y; Inoue K; Ito Y; Okoshi R; Kageyama H; Kimura H; Miyazaki M; Nakagawara A
    J Biol Chem; 2010 May; 285(22):16693-703. PubMed ID: 20353948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Runt-related transcription factor 1 (RUNX1) stimulates tumor suppressor p53 protein in response to DNA damage through complex formation and acetylation.
    Wu D; Ozaki T; Yoshihara Y; Kubo N; Nakagawara A
    J Biol Chem; 2013 Jan; 288(2):1353-64. PubMed ID: 23148227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive Activation of DNA Damage Checkpoint Signaling Contributes to Mutant p53 Accumulation via Modulation of p53 Ubiquitination.
    Frum RA; Love IM; Damle PK; Mukhopadhyay ND; Palit Deb S; Deb S; Grossman SR
    Mol Cancer Res; 2016 May; 14(5):423-36. PubMed ID: 26965143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of HDAC2 in chromatin remodelling and response to chemotherapy in ovarian cancer.
    Huang R; Langdon SP; Tse M; Mullen P; Um IH; Faratian D; Harrison DJ
    Oncotarget; 2016 Jan; 7(4):4695-711. PubMed ID: 26683361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ATM kinase inhibitor KU-55933 provides neuroprotection against hydrogen peroxide-induced cell damage via a γH2AX/p-p53/caspase-3-independent mechanism: Inhibition of calpain and cathepsin D.
    Chwastek J; Jantas D; Lasoń W
    Int J Biochem Cell Biol; 2017 Jun; 87():38-53. PubMed ID: 28341201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cells.
    Deng S; Yan T; Nikolova T; Fuhrmann D; Nemecek A; Gödtel-Armbrust U; Kaina B; Wojnowski L
    Br J Pharmacol; 2015 May; 172(9):2246-57. PubMed ID: 25521189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase 2 regulates doxorubicin (Dox) sensitivity of colorectal cancer cells by targeting ABCB1 transcription.
    Ye P; Xing H; Lou F; Wang K; Pan Q; Zhou X; Gong L; Li D
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):613-21. PubMed ID: 26846508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.